A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene
Clinical trial NCT07185347 · RECRUITING
Trial details
- NCT number
- NCT07185347
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-21
- Primary completion
- 2027-05-21
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.